Management and Key personnel

 

  • Per Andersson

    CEO

    Per Andersson has been the CEO of Xspray Pharma AB since 2006. Per Andersson has extensive experience from the medical industry, especially within patent work and strategies. Previous positions include Science Director at Gyros AB and Scientist at GE Healthcare.

    Education: Ph.D. in Analytical Chemistry, Stockholm university

    Other current activities: Chariman of the board of Robotic Lawn Care Sweden AB and Deputy of Journeyman Stockholm AB

    Holdings: 127,437 shares and 154,857 warrants, where 69,857 warrants are cotingent of the listing of the company on First North.

    Independent in relation to the larger shareholders but not in relation to the company.

    Per Andersson has extensive experience from the medical industry. Previous positions include Science Director at Gyros AB and Scientist at GE Healthcare.

    +46 (0)8 730 37 00

  • Andreas Konar

    Business Development

    Andreas Konar is highly experienced in all management aspects of drug-delivery companies. Previous experiences include positions at Astra, Recordatti and LifeCycle Pharma.

    Independent in relation to the larger shareholders but not in relation to the company.

  • Charlotta Liljebris

    Research and Development

    Charlotta Liljebris has more than 25 years of experience from the pharmaceutical industry, including as responsible for business development at Orexo, Vice President of Aprea, focusing on the development of oncology projects, and project management at Biovitrum.

    Education: Ph.D. in Pharmaceutical Chemistry, Uppsala University

    Other current activities: Board member of Sprint Bioscience

  • Kerstin Hasselgren

    CFO

    Bred erfarenhet från arbete I internationella börsnoterade företag såsom VP Corporate Business Control på SSAB, CFO på Alstom Transport Nordic, VP Finance Global Operations på AstraZeneca samt VP Finance Global R&D på AstraZeneca

    Utbildning: M.Sc. Business Administration, Stockholm School of Economics

    Andra pågående styrelseuppdrag; Inga

    Tidigare styrelseuppdrag (de senaste 5 åren); Inga

    Innehav i bolaget (aktier samt optioner) 4 500 aktier